Cipla's shares on Monday surged 9.2% to hit a new 52-week high of ₹696 on BSE. This comes after it was allowed to manufacture and supply antiviral drug remdesivir for treatment of suspected or confirmed cases of COVID-19. Shares of Glenmark Pharmaceuticals also surged 40%
